Cargando…
A novel duplication involving PRDM13 in a Turkish family supports its role in North Carolina macular dystrophy (NCMD/MCDR1)
PURPOSE: To clinically and molecularly investigate a new family with North Carolina macular dystrophy (NCMD) from Turkey, a previously unreported geographic origin for this phenotype. METHODS: Clinical ophthalmic examinations, including fundus imaging and spectral domain-optical coherence tomography...
Autores principales: | Small, Kent W., Van de Sompele, Stijn, Nuytemans, Karen, Vincent, Andrea, Yuregir, Ozge Ozalp, Ciloglu, Emine, Sariyildiz, Cahfer, Rosseel, Toon, Avetisjan, Jessica, Udar, Nitin, Vance, Jeffery M., Pericak-Vance, Margaret A., De Baere, Elfride, Shaya, Fadi S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Vision
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410230/ https://www.ncbi.nlm.nih.gov/pubmed/34526759 |
Ejemplares similares
-
Congenital toxoplasmosis as one phenocopy of North Carolina Macular Dystrophy (NCMD/MCDR1)
por: Small, Kent W., et al.
Publicado: (2019) -
North Carolina macular dystrophy (MCDR1) caused by a novel tandem duplication of the PRDM13 gene
por: Bowne, Sara J., et al.
Publicado: (2016) -
Duplication events downstream of IRX1 cause North Carolina macular dystrophy at the MCDR3 locus
por: Cipriani, Valentina, et al.
Publicado: (2017) -
Phenocopy of a heterozygous carrier of X-linked retinitis pigmentosa due to mosaicism for a RHO variant
por: Strubbe, Ine, et al.
Publicado: (2021) -
Multi-omics approach dissects cis-regulatory mechanisms underlying North Carolina macular dystrophy, a retinal enhanceropathy
por: Van de Sompele, Stijn, et al.
Publicado: (2022)